Kymera Therapeutics, Inc. · NASDAQ:KYMR

Mainolfi Nello sold 50,000 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jul 7, 2026 · Filed Jul 7, 2026

On Jul 7, 2026, Mainolfi Nello (Director, Chief Executive Officer) sold 50,000 Kymera Therapeutics, Inc. shares at US$119.00 for US$5.95M under a trading plan, leaving 666,568 shares. Filed Jul 7, 2026 (Form 4).

Sold
50,000 shares
Price
US$119.00
Value
US$5.95M
Holding after
666,568 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 7, 2026Common StockOption exercise50,000US$2.08716,568Direct
Jul 7, 2026Common StockSale50,000US$119.00666,568Direct

Source

View original at SEC

Related